Mylan Launching Generic Version of EpiPen | NECN
National & International News
The day’s top national and international news

Mylan Launching Generic Version of EpiPen

Consumers and politicians have accused the company of price-gouging, considering that the product has been on the market since 1987 and the price didn't start rising significantly until Mylan acquired it in 2007

    processing...

    NEWSLETTERS

    AP
    This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan, now in the crosshairs over severe price hikes for its EpiPen, said Thursday, Aug. 25, 2016, it will expand programs that lower out-of-pocket costs by as much as half.

    Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. 

    The company said Monday that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack — about half the current price. It will be available in both 0.15 mg and 0.30 mg strengths. 

    EpiPens are used in emergencies to treat severe allergies to insect bites and foods like nuts and eggs that can lead to anaphylactic shock. 

    People usually keep a number of EpiPens handy at home, school or work. The syringes, prefilled with the hormone epinephrine, expire after a year. 

    Pig Escapes Slaughterhouse Fate, Sells Original Paintings

    [NATL] Pig Escapes Slaughterhouse Fate, Sells Original Paintings

    A pig who escaped slaughter is now living out her life in a South African sanctuary and painting original works that have sold for up to $2,000.

    "She was really small when I rescued her," said Joanne Lefson, who manages the South African Farm Sanctuary, a haven for rescued farm animals where the pig now lives. "She's very smart and intelligent so I placed a few balls and some paintbrushes and things in her pen, and it wasn't long before I discovered that she really liked the bristles and the paintbrush...She just really took a knack for it."

    Funds from the art sales go towards the sanctuary.

    (Published 5 hours ago)

    Mylan N.V. said that it anticipates having the generic versions available in the next several weeks. It will continue to market and distribute a branded EpiPen. 

    The company charges $608 for a two-pack of the branded EpiPen. Mylan said it will keep in place the $300 savings card for the branded EpiPen and the revised patient assistance program announced last week. 

    Consumers and politicians have accused the company of price-gouging, considering that the product has been on the market since 1987 and the price didn't start rising significantly until Mylan acquired it in 2007. 

    There is also little competition, with the only rival product being Adrenaclick, which carries a list price of $461. 

    Clinton Gives First Major Post-Election Speech

    [NATL] Hillary Clinton Gives First Major Post-Election Speech at Event for Businesswomen

    Former Secretary of State Hillary Clinton gave her first major public speech on Tuesday since losing the 2016 presidential election, speaking at a meeting of the Professional Businesswomen of California organization in San Fransisco, California.

    (Published 2 hours ago)

    Mylan CEO Heather Bresch has defended the price hikes, saying the company only received $274 of the total price for a twin-package while insurers, pharmacies and other parties divvy up the rest. 

    People usually keep a number of EpiPens handy at home, school or work. The syringes, prefilled with the hormone epinephrine, expire after a year. 

    Numerous members of Congress and other politicians this week have called for congressional hearings on Mylan's pricing, an investigation by the Federal Trade Commission and action by the Food and Drug Administration to increase competition by speeding up approvals of any rival products. 

    At least two companies are trying to get U.S. approval to sell a rival brand or generic version of EpiPen. None is likely to hit the U.S. market until well into next year. Relief could come sooner from Imprimis Pharmaceuticals, a compounding pharmacy that prepares medicines to fill individual prescriptions. It said it might be able to sell a version in a few months and would likely charge around $100 for two injectors.